Skip to main content

Symvess acellular tissue engineered vessel for surgical vascular implantation Images

Generic Name: acellular tissue engineered vessel

This medication has been identified as Symvess acellular tissue engineered vessel for surgical vascular implantation. It is supplied by Humacyte Global, Inc.

Symvess is used in the treatment of Revascularization Procedures.

Images of medication

Symvess acellular tissue engineered vessel for surgical vascular implantation medicine

Symvess

Generic Name
acellular tissue engineered vessel
Strength
acellular tissue engineered vessel for surgical vascular implantation
CSA Schedule
Unknown
Labeler / Supplier
Humacyte Global, Inc.
National Drug Code (NDC)
83564-0110

Get help with Imprint Code FAQs.

See also:

More about Symvess (acellular tissue engineered vessel)

Professional resources

Related treatment guides

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.